Avid Bioservices (CDMO) Tops Q4 EPS by 12c

Avid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.03), $0.12 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.94 million versus the consensus estimate of $6.14 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Middleby board approves spin-off of food processing unit Midera
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings